Cannabis

  • April 01, 2026

    Berkshire Must Defend Trulieve In Worker Death Suit

    An insurance company that is a unit of Berkshire Hathaway had an obligation to defend Trulieve Inc. against a Massachusetts wrongful death lawsuit brought by the family of a cannabis worker, a Florida federal judge has ruled, rejecting arguments that the worker wasn't an employee.

  • April 01, 2026

    Wash. Smoke Shops, Insurer Settle Kratom Death Suit

    An insurance company has reached a deal with two Washington smoke shops to end a dispute in which the insurer argued its policies did not cover defending retailers in a suit by a father who claims they sold kratom products that killed his son.

  • April 01, 2026

    DC Cannabis Co. Sues Firm Over Botched Grow Facility

    A cannabis industry-focused engineering firm reneged on a promise to build a fully operational indoor grow facility for a D.C.-based medical dispensary, the company told a D.C. federal court, claiming it is now stuck with the unfinished project and $1 million in specialized equipment that can't be resold.

  • April 01, 2026

    9th Circ. Nixes 3-Strikes Enhancement In Meth Conviction

    The Ninth Circuit has ordered that a new sentence for drug trafficking be given to a man who successfully argued in a self-filed motion that his attorney failed to challenge a sentence enhancement for career offenders.

  • April 01, 2026

    Mass. Cannabis Businesses Say Repeal Bid Misleads Voters

    A coalition of Massachusetts cannabis business owners Wednesday challenged the constitutionality of a proposal to repeal retail marijuana legalization at the ballot box this November.

  • March 31, 2026

    Rats, Vapes And Vodka: Strange But True Cases For April Fool's

    A dead rodent in a burrito bowl delivery, a mix-up with vodka seltzer in the wrong cans and the Toys R Us brand taking on a Connecticut vape shop are among Law360's list of strange cases suitable for April Fool's Day.

  • March 31, 2026

    Wrigley Heir Beats Pot Co. Ex-Execs' Fraud Suit, For Now

    The former CEO of medical marijuana company Parallel, the scion to the Wrigley gum fortune, has, for now, beaten a lawsuit accusing him of lying about share prices to lure executive talent, with an Atlanta federal judge slamming the suit as "threadbare" and "devoid of even the most basic facts" about the company.

  • March 31, 2026

    SEIU Arbitration Suit Strains Order, Hospital Says

    A Service Employees International Union unit is stretching an arbitrator's finding that a hospital unfairly punished a worker who tested positive for cannabis use by seeking to restrict drug tests going forward, the hospital argued Tuesday in its bid to beat an Ohio federal suit.

  • March 31, 2026

    Pot Opponents Seek To Block CMS Hemp Benefit Program

    A coalition of anti-cannabis activists is suing federal health regulators to block a program designed to reimburse Medicare beneficiaries for the use of federally legal hemp products that have small amounts of THC.

  • March 31, 2026

    Sanctions Nixed In Suit Over Calif. County's Hemp Destruction

    A California federal judge has vacated sanctions imposed on Kern County's attorney in a suit alleging the county and state law enforcement illegally destroyed 500 acres of legal hemp owned by Apothio LLC, saying a magistrate judge didn't follow the proper rules in imposing those sanctions.

  • March 30, 2026

    Law Firm Blew Fraud Suit Against Ex-Partners, Pot Co. Says

    A law firm overbilled, underworked and generally dropped the ball in a fraud suit brought by a cannabis cultivator and manufacturer against ex-business partners, the company told a California state court, saying it's seeking at least $500,000 from the firm.

  • March 30, 2026

    Product Liability Q1 Regulatory Roundup

    In the first three months of 2026, executive orders and other regulatory actions by the Trump administration have taken on products with "Made in America" labeling, called for the increased manufacture of the herbicide ingredient glyphosate, and addressed what e-cigarette flavors could receive the U.S. Food and Drug Administration's approval, among others.

  • March 30, 2026

    Michigan Overtaxes Marijuana Sales, Industry Group Claims

    Michigan's new tax on marijuana sales has resulted in an effective tax rate that's higher than the constitution permits, a group representing the cannabis industry claimed in a new lawsuit Monday.

  • March 30, 2026

    EEOC Accuses Dispensary Of Rampant Sexual Harassment

    Male employees at an Illinois cannabis dispensary sexually harassed their female colleagues on a "near-daily" basis, which forced at least one woman to quit, the U.S. Equal Employment Opportunity Commission told a federal court Monday.

  • March 30, 2026

    Tilray Accused Of Dodging $11M In Bob Marley Royalties

    Multistate cannabis giant Tilray owes more than $11 million in royalty payments for using Bob Marley's brand in connection with marijuana products, according to a new lawsuit filed in Delaware Chancery Court.

  • March 30, 2026

    Kratom Addictiveness 9th Circ. Appeal Dropped

    A group of consumers told the Ninth Circuit on Friday that they were dropping the appeal of a dismissal of their suit over kratom products that they said were as addictive as opioids.

  • March 30, 2026

    Md. Officials Immune In Challenge To Pot, Hemp Rules

    A Maryland federal judge has thrown out a challenge by hemp sellers, farmers and a consumer to Maryland's new rules requiring a cannabis license to sell intoxicating hemp products, finding that the state officials have sovereign immunity.

  • March 27, 2026

    Hemp Co. Seeks To Cancel Popular 'Lost Mary' Vape TM

    A North Carolina hemp provider is looking to cancel the popular "Lost Mary" vape trademark, held by the Chinese company that also sells Elf Bars, telling a California federal court that it was always invalid because it's illegal to sell flavored vapes.

  • March 27, 2026

    Delaware Judge Lets Juul Suits Proceed, Trims Claims

    Delaware Superior Court has largely allowed a set of lawsuits against Juul Labs Inc. to move forward, rejecting the company's bid to dismiss claims brought by more than a thousand plaintiffs who say they were misled about the risks of its e-cigarettes.

  • March 27, 2026

    Sens. Push Bill To Equip VA For Psychedelic Therapies

    A bipartisan group of U.S. senators has introduced legislation to broaden veterans' access to emerging therapies, including psychedelic-assisted treatments, that may be effective in addressing post-traumatic stress disorder and other mental health issues.

  • March 27, 2026

    Mississippi Gov. Vetoes Medical Marijuana Expansion Bill

    Mississippi Gov. Tate Reeves has vetoed a bill to expand the state's medical cannabis program to include severely ill patients, while approving another bill to fund a clinical trial into the psychedelic ibogaine.

  • March 27, 2026

    Texas Calls Vape Sellers' Suit Over China Law 'Speculative'

    The Texas Comptroller of Public Accounts is urging a federal court to throw out a suit from a group of vape sellers challenging a new law banning the sale of e-cigarette products that use liquids from China and other "adversaries," saying they don't have standing to sue.

  • March 26, 2026

    Ill. Judge Tosses 'Baseless' THC Potency Suit

    Illinois cannabis regulators are not so "incompetent on an elementary level" as to be duped into allowing Acreage Holdings Inc. and other companies to mislabel vape products in a way that lets them skirt state-imposed THC-potency limits, a federal court ruled, tossing as "baseless" a consumer-led proposed class action.

  • March 26, 2026

    Elon Musk Slams Twitter Stock Verdict Over Jury's $4.20 'Joke'

    Elon Musk did not get a fair trial over claims he defrauded Twitter investors before acquiring the social media platform, the tech billionaire's lawyer told a California federal judge Thursday, saying the jury rolled a marijuana "joke" into the verdict form to mock Musk and the trial process.

  • March 26, 2026

    Legislative Update: Cannabis And Psychedelics Bill Roundup

    Lawmakers at the state and federal level stewarded legislation to rein in kratom and its derivatives, Idaho lawmakers took a stand against a proposal to legalize medical marijuana via ballot initiative, and New York legislators introduced a plan to audit the state's cannabis regulator on an annual basis. Here are the major moves in cannabis and psychedelics legislation from the past week.

Expert Analysis

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • 2025 Legal Milestones That Will Shape Psychedelics Sector

    Author Photo

    As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented momentum through recent sweeping regulatory changes and landmark clinical milestones, amid rapidly evolving regulatory expectations, say Odette Hauke at Odette Alina LLC and Kimberly Chew at Husch Blackwell.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

  • Series

    The Law Firm Merger Diaries: Integrating Practice Groups

    Author Photo

    Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.

  • Opinion

    Supreme Court Term Limits Would Carry Hidden Risk

    Author Photo

    While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Series

    Knitting Makes Me A Better Lawyer

    Author Photo

    Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.

  • Series

    The Biz Court Digest: Welcome To Miami

    Author Photo

    After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.

  • AI Evidence Rule Tweaks Encourage Judicial Guardrails

    Author Photo

    Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.

  • Series

    The Law Firm Merger Diaries: Getting The Message Across

    Author Photo

    Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.

  • Opinion

    Horizontal Stare Decisis Should Not Be Casually Discarded

    Author Photo

    Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Cannabis archive.